1. Home
  2. ADV vs CLLS Comparison

ADV vs CLLS Comparison

Compare ADV & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advantage Solutions Inc.

ADV

Advantage Solutions Inc.

HOLD

Current Price

$39.26

Market Cap

438.2M

ML Signal

HOLD

Logo Cellectis S.A.

CLLS

Cellectis S.A.

HOLD

Current Price

$3.72

Market Cap

384.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADV
CLLS
Founded
1987
1999
Country
United States
France
Employees
73000
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
438.2M
384.3M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
ADV
CLLS
Price
$39.26
$3.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$45.83
$8.33
AVG Volume (30 Days)
68.0K
25.8K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.63
N/A
Revenue Next Year
$0.45
$0.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$1.33
52 Week High
$38.78
$5.48

Technical Indicators

Market Signals
Indicator
ADV
CLLS
Relative Strength Index (RSI) 77.88 53.05
Support Level $1.00 $3.93
Resistance Level N/A $4.54
Average True Range (ATR) 3.07 0.15
MACD -0.22 -0.03
Stochastic Oscillator 100.00 33.33

Price Performance

Historical Comparison
ADV
CLLS

About ADV Advantage Solutions Inc.

Advantage Solutions Inc provides outsourced sales, marketing, merchandising, sampling, and retailer support services to consumer packaged goods manufacturers and retailers across North America. Its services are designed to support distribution, retail execution, shopper engagement, and private brand development across both physical and digital commerce environments. The company serves various clients across grocery, mass, club, retail pharmacy, convenience, and other channels. It operates through three reportable segments: Branded Services, Experiential Services, and Retailer Services. The majority of the revenue is derived from the Experiential Services segment, which provides in-store and digital sampling programs, demonstrations, and experiential events for manufacturers and retailers.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: